CD4 and endometrial cancer: Evidence in support of this theory is the observation that tumor infiltrating [49] and peritumoral lymphocytes are increased and that cytotoxic activities in CD8+ and CD4+ lymphocyte populations are heightened in POLE mutated endometrial cancers [50–53], similar to hypermutated MSI tumors [54].